# Monolithic Power Systems, Inc.: financial statements, quarterly

MPWR · Nasdaq · CIK 1280452 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mpwr.md) · [Financials](/companies/mpwr/financials.md) · [Filings](/companies/mpwr/filings.md) · [Insiders](/companies/mpwr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mpwr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [475](/filings/0001437749-24-033608.md) | [454 d](/filings/0001437749-26-006113.md) | [458](/filings/0001437749-25-014522.md) | [507](/filings/0001437749-25-024602.md) | [620](/filings/0001437749-25-033332.md) | [622 d](/filings/0001437749-26-006113.md) | [638](/filings/0001437749-26-014647.md) | [665](/filings/0001628280-26-053275.md) | [737](/filings/0001437749-26-006113.md) | [751 d](/filings/0001437749-26-006113.md) | [804](/filings/0001437749-26-014647.md) | [981](/filings/0001628280-26-053275.md) |
| Cost of revenue | $m | [211](/filings/0001437749-24-033608.md) | [203 d](/filings/0001437749-26-006113.md) | [205](/filings/0001437749-25-014522.md) | [227](/filings/0001437749-25-024602.md) | [277](/filings/0001437749-25-033332.md) | [277 d](/filings/0001437749-26-006113.md) | [284](/filings/0001437749-26-014647.md) | [299](/filings/0001628280-26-053275.md) | [331](/filings/0001437749-26-006113.md) | [337 d](/filings/0001437749-26-006113.md) | [359](/filings/0001437749-26-014647.md) | [440](/filings/0001628280-26-053275.md) |
| Gross profit | $m | [264](/filings/0001437749-24-033608.md) | [251 d](/filings/0001437749-26-006113.md) | [252](/filings/0001437749-25-014522.md) | [281](/filings/0001437749-25-024602.md) | [343](/filings/0001437749-25-033332.md) | [344 d](/filings/0001437749-26-006113.md) | [353](/filings/0001437749-26-014647.md) | [366](/filings/0001628280-26-053275.md) | [406](/filings/0001437749-26-006113.md) | [414 d](/filings/0001437749-26-006113.md) | [445](/filings/0001437749-26-014647.md) | [541](/filings/0001628280-26-053275.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [63.2](/filings/0001437749-24-033608.md) | [70.1 d](/filings/0001437749-26-006113.md) | [81.0](/filings/0001437749-25-014522.md) | [86.1](/filings/0001437749-25-024602.md) | [94.4](/filings/0001437749-25-033332.md) | [95.3 d](/filings/0001437749-26-006113.md) | [92.2](/filings/0001437749-26-014647.md) | [105](/filings/0001628280-26-053275.md) | [113](/filings/0001437749-26-006113.md) | [119 d](/filings/0001437749-26-006113.md) | [103](/filings/0001437749-26-014647.md) | [119](/filings/0001628280-26-053275.md) |
| Operating income | $m | [136](/filings/0001437749-24-033608.md) | [110 d](/filings/0001437749-26-006113.md) | [95.5](/filings/0001437749-25-014522.md) | [117](/filings/0001437749-25-024602.md) | [164](/filings/0001437749-25-033332.md) | [163 d](/filings/0001437749-26-006113.md) | [169](/filings/0001437749-26-014647.md) | [165](/filings/0001628280-26-053275.md) | [195](/filings/0001437749-26-006113.md) | [200 d](/filings/0001437749-26-006113.md) | [241](/filings/0001437749-26-014647.md) | [304](/filings/0001628280-26-053275.md) |
| Income tax | $m | [16.7](/filings/0001437749-24-033608.md) | [22.6 d](/filings/0001437749-26-006113.md) | [12.5](/filings/0001437749-25-014522.md) | [23.7](/filings/0001437749-25-024602.md) | [29.9](/filings/0001437749-25-033332.md) | [(1,085) d](/filings/0001437749-26-006113.md) | [38.8](/filings/0001437749-26-014647.md) | [42.0](/filings/0001628280-26-053275.md) | [25.8](/filings/0001437749-26-006113.md) | [38.1 d](/filings/0001437749-26-006113.md) | [54.0](/filings/0001437749-26-014647.md) | [64.4](/filings/0001628280-26-053275.md) |
| Net income | $m | [121](/filings/0001437749-24-033608.md) | [96.9 d](/filings/0001437749-26-006113.md) | [92.5](/filings/0001437749-25-014522.md) | [100](/filings/0001437749-25-024602.md) | [144](/filings/0001437749-25-033332.md) | [1,255 d](/filings/0001437749-26-006113.md) | [135](/filings/0001437749-26-014647.md) | [135](/filings/0001628280-26-053275.md) | [180](/filings/0001437749-26-006113.md) | [172 d](/filings/0001437749-26-006113.md) | [193](/filings/0001437749-26-014647.md) | [257](/filings/0001628280-26-053275.md) |
| Diluted EPS | $ per share | [2.48](/filings/0001437749-24-033608.md) | not reported | [1.89](/filings/0001437749-25-014522.md) | [2.05](/filings/0001437749-25-024602.md) | [2.95](/filings/0001437749-25-033332.md) | not reported | [2.81](/filings/0001437749-26-014647.md) | [2.81](/filings/0001628280-26-053275.md) | [3.74](/filings/0001437749-26-006113.md) | not reported | [3.92](/filings/0001437749-26-014647.md) | [5.22](/filings/0001628280-26-053275.md) |
| Basic EPS | $ per share | [2.54](/filings/0001437749-24-033608.md) | not reported | [1.90](/filings/0001437749-25-014522.md) | [2.06](/filings/0001437749-25-024602.md) | [2.96](/filings/0001437749-25-033332.md) | not reported | [2.82](/filings/0001437749-26-014647.md) | [2.82](/filings/0001628280-26-053275.md) | [3.75](/filings/0001437749-26-006113.md) | not reported | [3.94](/filings/0001437749-26-014647.md) | [5.24](/filings/0001628280-26-053275.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [421](/filings/0001437749-23-030929.md) | [528](/filings/0001437749-26-006113.md) | [488](/filings/0001437749-24-014648.md) | [550](/filings/0001437749-24-024477.md) | [700](/filings/0001437749-24-033608.md) | [692](/filings/0001437749-26-006113.md) | [637](/filings/0001437749-26-014647.md) | [787](/filings/0001628280-26-053275.md) | [1,081](/filings/0001437749-26-006113.md) | [1,099](/filings/0001628280-26-053275.md) | [1,063](/filings/0001437749-26-014647.md) | [1,006](/filings/0001628280-26-053275.md) |
| Current assets | $m | [1,735](/filings/0001437749-23-030929.md) | [1,819](/filings/0001437749-25-005903.md) | [1,976](/filings/0001437749-24-014648.md) | [1,997](/filings/0001437749-24-024477.md) | [2,160](/filings/0001437749-24-033608.md) | [1,565](/filings/0001437749-26-006113.md) | [1,788](/filings/0001437749-26-006113.md) | [1,919](/filings/0001437749-26-006113.md) | [2,113](/filings/0001437749-26-006113.md) | [2,184](/filings/0001628280-26-053275.md) | [2,331](/filings/0001437749-26-014647.md) | [2,477](/filings/0001628280-26-053275.md) |
| Total assets | $m | [2,328](/filings/0001437749-23-030929.md) | [2,434](/filings/0001437749-25-005903.md) | [2,579](/filings/0001437749-24-014648.md) | [2,648](/filings/0001437749-24-024477.md) | [2,855](/filings/0001437749-24-033608.md) | [3,516](/filings/0001437749-26-006113.md) | [3,705](/filings/0001437749-26-006113.md) | [3,872](/filings/0001437749-26-006113.md) | [4,107](/filings/0001437749-26-006113.md) | [4,194](/filings/0001628280-26-053275.md) | [4,449](/filings/0001437749-26-014647.md) | [4,686](/filings/0001628280-26-053275.md) |
| Current liabilities | $m | [250](/filings/0001437749-23-030929.md) | [235](/filings/0001437749-25-005903.md) | [312](/filings/0001437749-24-014648.md) | [295](/filings/0001437749-24-024477.md) | [337](/filings/0001437749-24-033608.md) | [295](/filings/0001437749-26-006113.md) | [363](/filings/0001437749-26-006113.md) | [384](/filings/0001437749-26-006113.md) | [443](/filings/0001437749-26-006113.md) | [369](/filings/0001628280-26-053275.md) | [487](/filings/0001437749-26-014647.md) | [498](/filings/0001628280-26-053275.md) |
| Total liabilities | $m | [383](/filings/0001437749-23-030929.md) | [384](/filings/0001437749-25-005903.md) | [465](/filings/0001437749-24-014648.md) | [452](/filings/0001437749-24-024477.md) | [503](/filings/0001437749-24-033608.md) | [565](/filings/0001437749-26-006113.md) | [632](/filings/0001437749-26-006113.md) | [662](/filings/0001437749-26-006113.md) | [730](/filings/0001437749-26-006113.md) | [663](/filings/0001628280-26-053275.md) | [771](/filings/0001437749-26-014647.md) | [791](/filings/0001628280-26-053275.md) |
| Shareholders' equity | $m | [1,945](/filings/0001437749-24-033608.md) | [2,050](/filings/0001437749-26-006113.md) | [2,114](/filings/0001437749-25-024602.md) | [2,196](/filings/0001437749-25-033332.md) | [2,352](/filings/0001437749-25-033332.md) | [2,951](/filings/0001628280-26-053275.md) | [3,074](/filings/0001628280-26-053275.md) | [3,210](/filings/0001628280-26-053275.md) | [3,377](/filings/0001437749-26-006113.md) | [3,531](/filings/0001628280-26-053275.md) | [3,677](/filings/0001628280-26-053275.md) | [3,895](/filings/0001628280-26-053275.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [176 d](/filings/0001437749-24-033608.md) | [153 d](/filings/0001437749-26-006113.md) | [248](/filings/0001437749-25-014522.md) | [141 d](/filings/0001437749-25-024602.md) | [232 d](/filings/0001437749-25-033332.md) | [168 d](/filings/0001437749-26-006113.md) | [256](/filings/0001437749-26-014647.md) | [238 d](/filings/0001628280-26-053275.md) | [239 d](/filings/0001437749-25-033332.md) | [105 d](/filings/0001437749-26-006113.md) | [250](/filings/0001437749-26-014647.md) | [228 d](/filings/0001628280-26-053275.md) |
| Capital expenditure | $m | [27.1 d](/filings/0001437749-24-033608.md) | [13.8 d](/filings/0001437749-26-006113.md) | [16.0](/filings/0001437749-25-014522.md) | [31.5 d](/filings/0001437749-25-024602.md) | [33.8 d](/filings/0001437749-25-033332.md) | [64.8 d](/filings/0001437749-26-006113.md) | [40.3](/filings/0001437749-26-014647.md) | [48.1 d](/filings/0001628280-26-053275.md) | [42.5 d](/filings/0001437749-25-033332.md) | [41.0 d](/filings/0001437749-26-006113.md) | [70.8](/filings/0001437749-26-014647.md) | [82.4 d](/filings/0001628280-26-053275.md) |
| Dividends paid | $m | [49.4 d](/filings/0001437749-24-033608.md) | [50.6 d](/filings/0001437749-26-006113.md) | [49.6](/filings/0001437749-25-014522.md) | [68.1 d](/filings/0001437749-25-024602.md) | [61.2 d](/filings/0001437749-25-033332.md) | [61.9 d](/filings/0001437749-26-006113.md) | [60.0](/filings/0001437749-26-014647.md) | [75.1 d](/filings/0001628280-26-053275.md) | [74.9 d](/filings/0001437749-25-033332.md) | [74.8 d](/filings/0001437749-26-006113.md) | [78.4](/filings/0001437749-26-014647.md) | [101 d](/filings/0001628280-26-053275.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-033608.md) | [3.7 d](/filings/0001437749-26-006113.md) | [4.1](/filings/0001437749-25-014522.md) | [4.5](/filings/0001437749-25-024602.md) | [5.5](/filings/0001437749-25-033332.md) | [622 d](/filings/0001437749-26-006113.md) | [0.0](/filings/0001437749-25-014522.md) | [2.6](/filings/0001437749-25-024602.md) | [2.1](/filings/0001437749-25-033332.md) | [1.9 d](/filings/0001437749-26-006113.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.3](/filings/0001437749-23-030929.md) | [48.7](/filings/0001437749-24-014648.md) | [48.8](/filings/0001437749-24-024477.md) | [48.8](/filings/0001437749-24-033608.md) | [48.9](/filings/0001437749-25-014522.md) | [48.9](/filings/0001437749-25-024602.md) | [49.0](/filings/0001437749-25-033332.md) | [48.0](/filings/0001437749-26-014647.md) | [48.0](/filings/0001628280-26-053275.md) | [48.0](/filings/0001437749-26-006113.md) | [49.2](/filings/0001437749-26-014647.md) | [49.3](/filings/0001628280-26-053275.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,143,000 at 2026-07-29, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053275.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.